| Product News
uLthera, inC
Micro-focused ultrasound
UlthErAPY®
Application Micro-focused ultrasound for lifting and toning lax skin Achieving consistent, non-invasive facial tissue lifting has just become more exciting. Ultherapy users may now target tissue at a whole new level, 1.5mm beneath the surface of the skin, to consistently affect superficial facial skin. Until now, Ultherapy users have had the ability to precisely and consistently coagulate tissue at 65°C at 4.5 and 3mm of depth, but with the launch of a new superficial transducer, they can now place tiny individual energy deposits at 1.5mm—and more profoundly affect the dermis as a result. Unlike existing energy based devices, Ultherapy creates discrete 1mm3 thermal coagulation points that are completely surrounded by healthy tissue, and will thus serve to maximise the benefits to the patient while completely eliminating any downtime. Early clinical results have shown that in using the novel DeepSEE™ technology at the new depth of 1.5mm, patients have experienced positive superficial effects. Combining this depth with the deeper focused transducers, treating at a dual or even triple layer of depth, Ultherapy is reaching significant effects both at the structural level of the facial tissue, as well as at the surface.
Contact Ulthera●
www.ulthera.com EMAA Stand Number C-18
Lab domaVmm (suisse) inC
Stem cell technology Application
parenterally MFIII
mfiiinAnocEll EXtrActS
Sublingually, topically or of
ediPeC sCCL Aesthetic accessory
SinGlE-USE micro- cAnnUlAE
Application Bioplasty EDIPEC, leading firm in the field of surgical instruments for plastic and aesthetic surgery, offers a wide range of flexible micro-cannulae for use with dermal fillers and hyaluronic acid. Our micro-cannulae will assist in safe micro-injection thanks to the lateral discharge port and the blunt tip that avoid damage to vessels. The cannulae range from 21G to 30G. Best sellers are 25Gx40mm, 27Gx40mm and 30Gx25mm.
Contact Edipec●
www.edipec.com EMAA Stand Number A-10
Switzerland Nano Cell Extracts are organ-specific cellular extracts of 3nanometers in size and less than 10kDa in molecular mass, a proud achievement following decades of thorough research and clinical experiment. These fresh cell extracts are ecologically procured as non-pathogenic, non-allergenic and sterile compounds through an advanced parallel-extraction process at MFIII’s European stem cell plant. This proprietary process selectively retrieves cellular material from foetal cells/ tissues into molecule-level ultrafiltrates—a biological preparation that is 100% natural and rules out any artificial additives. With over 50 organ- types available, MFIII Nano Cell Extracts have been attested by a number of accreditations from rigorous licensing and quality control boards worldwide. They are sourced from European-state-certified closed-colony of rabbits, bred for at least 30 generations since 1973, with full compliance to guidelines stipulated by WHO, USA-FDA and the AAALAC International.
Contact MFIII of Switzerland●
www.mf3-nano.com;
www.labdom.com EMAA Stand Number C-12
prime-journal.com | September 2011 ❚ 73
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76